化学
骨形态发生蛋白2
壳聚糖
细胞生物学
骨形态发生蛋白
激活剂(遗传学)
自愈水凝胶
下调和上调
炎症
输送系统
骨愈合
转录因子
生物医学工程
信号转导
成骨细胞
低聚糖
贾纳斯激酶
STAT蛋白
生物化学
激酶
癌症研究
转染
抄写(语言学)
分子生物学
作者
Jiacheng Zou,Xinzhu Zhou,Mu Lin,Xi Tian,Xin Deng,Huanzong He,L. Xiao,P. Y. Li,Juan Liao
出处
期刊:Biomacromolecules
[American Chemical Society]
日期:2025-12-24
卷期号:27 (1): 322-336
被引量:3
标识
DOI:10.1021/acs.biomac.5c01433
摘要
Inflammatory bone defects are difficult to treat because of their complex morphology and the inefficiency of bone induction with current methods. Peptidomics of periodontal tissues from patients with inflammatory bone defects and controls identified a novel 19-residue peptide, MESPtide, which was formulated into microspheres within an injectable hydrogel containing chitosan oligosaccharide (i-P@COS). The hydrogel rapidly shed chitosan oligosaccharide, resulting in anti-inflammatory effects, and then gradually released the peptide, which produced both anti-inflammatory and osteogenic effects in cultures of MC3T3-E1 cells and in a rat model of inflammatory bone defects. These osteogenic effects involved the upregulation of bone morphogenetic protein 2 (BMP2) and runt-related transcription factor 2 (RUNX2), as well as activation of signaling by Janus kinase 1 (JAK1) and signal transducer and activator of transcription 3 (STAT3). This microsphere-hydrogel delivery system shows promise for the stepwise treatment of inflammatory bone defects.
科研通智能强力驱动
Strongly Powered by AbleSci AI